Metraipolis › archive › dc_70a4ff2aedfd

Optimizing Tedizolid Dosing in Cerebral Nocardiosis: Clinical Impact of Direct Unbound Concentration Measurement and Population PK Modelling in Two Cases — Europe PMC PMID:41623529

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41623529
DOI: 10.1093/jacamr/dlag004
License (as archived): solo-consultazione
Archived: 2026-11-06T10:41:53.740Z
SHA-256 of the archived text: 62cdee99edfbfd08201495153fd48695a40f7cc2e090e54c31307560b91426c5
Stable URL of this page: https://metraipolis.com/documento/dc_70a4ff2aedfd

How to cite

Optimizing Tedizolid Dosing in Cerebral Nocardiosis: Clinical Impact of Direct Unbound Concentration Measurement and Population PK Modelling in Two Cases — Europe PMC PMID:41623529 — Europe PMC (en), https://europepmc.org/article/MED/41623529 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_70a4ff2aedfd (Metraipolis archive dc_70a4ff2aedfd, sha256 62cdee99edfbfd08201495153fd48695a40f7cc2e090e54c31307560b91426c5)

BibTeX

@misc{dc70a4ff2aedfd,
  title = {Optimizing Tedizolid Dosing in Cerebral Nocardiosis: Clinical Impact of Direct Unbound Concentration Measurement and Population PK Modelling in Two Cases — Europe PMC PMID:41623529},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41623529},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_70a4ff2aedfd; sha256 62cdee99edfbfd08201495153fd48695a40f7cc2e090e54c31307560b91426c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41623529. Agents can read the archived copy with the MCP tool read_document.